ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2013-10-19
    Description: We describe the construction and characterization of a genomically recoded organism (GRO). We replaced all known UAG stop codons in Escherichia coli MG1655 with synonymous UAA codons, which permitted the deletion of release factor 1 and reassignment of UAG translation function. This GRO exhibited improved properties for incorporation of nonstandard amino acids that expand the chemical diversity of proteins in vivo. The GRO also exhibited increased resistance to T7 bacteriophage, demonstrating that new genetic codes could enable increased viral resistance.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Lajoie, Marc J -- Rovner, Alexis J -- Goodman, Daniel B -- Aerni, Hans-Rudolf -- Haimovich, Adrian D -- Kuznetsov, Gleb -- Mercer, Jaron A -- Wang, Harris H -- Carr, Peter A -- Mosberg, Joshua A -- Rohland, Nadin -- Schultz, Peter G -- Jacobson, Joseph M -- Rinehart, Jesse -- Church, George M -- Isaacs, Farren J -- 1DP5OD009172-01/OD/NIH HHS/ -- DP5 OD009172/OD/NIH HHS/ -- K01 DK089006/DK/NIDDK NIH HHS/ -- K01DK089006/DK/NIDDK NIH HHS/ -- T32 GM007205/GM/NIGMS NIH HHS/ -- T32GM07205/GM/NIGMS NIH HHS/ -- New York, N.Y. -- Science. 2013 Oct 18;342(6156):357-60. doi: 10.1126/science.1241459.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/24136966" target="_blank"〉PubMed〈/a〉
    Keywords: Amino Acid Substitution/genetics ; Amino Acids/*genetics ; Bacteriophage T7/*physiology ; Codon, Terminator/*genetics ; Escherichia coli/*genetics/*virology ; Escherichia coli Proteins/genetics ; Genetic Engineering ; Genome, Bacterial ; Organisms, Genetically Modified/*genetics/*virology ; Peptide Chain Termination, Translational/genetics ; Peptide Termination Factors/genetics
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2015-09-30
    Description: 〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Rovner, Alexis J -- Haimovich, Adrian D -- Katz, Spencer R -- Li, Zhe -- Grome, Michael W -- Gassaway, Brandon M -- Amiram, Miriam -- Patel, Jaymin R -- Gallagher, Ryan R -- Rinehart, Jesse -- Isaacs, Farren J -- England -- Nature. 2015 Nov 12;527(7577):264. doi: 10.1038/nature15537. Epub 2015 Sep 23.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/26416756" target="_blank"〉PubMed〈/a〉
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    Publication Date: 2015-01-22
    Description: Genetically modified organisms (GMOs) are increasingly used in research and industrial systems to produce high-value pharmaceuticals, fuels and chemicals. Genetic isolation and intrinsic biocontainment would provide essential biosafety measures to secure these closed systems and enable safe applications of GMOs in open systems, which include bioremediation and probiotics. Although safeguards have been designed to control cell growth by essential gene regulation, inducible toxin switches and engineered auxotrophies, these approaches are compromised by cross-feeding of essential metabolites, leaked expression of essential genes, or genetic mutations. Here we describe the construction of a series of genomically recoded organisms (GROs) whose growth is restricted by the expression of multiple essential genes that depend on exogenously supplied synthetic amino acids (sAAs). We introduced a Methanocaldococcus jannaschii tRNA:aminoacyl-tRNA synthetase pair into the chromosome of a GRO derived from Escherichia coli that lacks all TAG codons and release factor 1, endowing this organism with the orthogonal translational components to convert TAG into a dedicated sense codon for sAAs. Using multiplex automated genome engineering, we introduced in-frame TAG codons into 22 essential genes, linking their expression to the incorporation of synthetic phenylalanine-derived amino acids. Of the 60 sAA-dependent variants isolated, a notable strain harbouring three TAG codons in conserved functional residues of MurG, DnaA and SerS and containing targeted tRNA deletions maintained robust growth and exhibited undetectable escape frequencies upon culturing approximately 10(11) cells on solid media for 7 days or in liquid media for 20 days. This is a significant improvement over existing biocontainment approaches. We constructed synthetic auxotrophs dependent on sAAs that were not rescued by cross-feeding in environmental growth assays. These auxotrophic GROs possess alternative genetic codes that impart genetic isolation by impeding horizontal gene transfer and now depend on the use of synthetic biochemical building blocks, advancing orthogonal barriers between engineered organisms and the environment.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590768/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590768/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Rovner, Alexis J -- Haimovich, Adrian D -- Katz, Spencer R -- Li, Zhe -- Grome, Michael W -- Gassaway, Brandon M -- Amiram, Miriam -- Patel, Jaymin R -- Gallagher, Ryan R -- Rinehart, Jesse -- Isaacs, Farren J -- K01 DK089006/DK/NIDDK NIH HHS/ -- T32 GM007205/GM/NIGMS NIH HHS/ -- T32GM07205/GM/NIGMS NIH HHS/ -- England -- Nature. 2015 Feb 5;518(7537):89-93. doi: 10.1038/nature14095. Epub 2015 Jan 21.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉1] Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA [2] Systems Biology Institute, Yale University, West Haven, Connecticut 06516, USA. ; 1] Systems Biology Institute, Yale University, West Haven, Connecticut 06516, USA [2] Department of Cellular and Molecular Physiology, Yale University, New Haven, Connecticut 06520, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/25607356" target="_blank"〉PubMed〈/a〉
    Keywords: Amino Acids/*chemical synthesis/chemistry/metabolism/*pharmacology ; Amino Acyl-tRNA Synthetases/genetics/metabolism ; Catalytic Domain/genetics ; Codon/genetics ; Containment of Biohazards/*methods ; Culture Media/chemistry/pharmacology ; Environment ; Escherichia coli/cytology/*drug effects/*genetics/metabolism ; Escherichia coli Proteins/biosynthesis/chemistry/genetics/metabolism ; Evolution, Molecular ; Gene Transfer, Horizontal/genetics ; Genes, Essential/genetics ; Genetic Code/genetics ; Genetic Engineering/methods ; Genome, Bacterial/genetics ; Microbial Viability/*drug effects/genetics ; Molecular Sequence Data ; Organisms, Genetically Modified/genetics/growth & development/metabolism ; Peptide Termination Factors/genetics ; Phenylalanine/chemistry/metabolism ; Protein Multimerization/genetics ; RNA, Transfer/genetics ; Synthetic Biology/*methods
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 4
    Publication Date: 2015-02-18
    Description: Genetically modified organisms (GMOs) are commonly used to produce valuable compounds in closed industrial systems. However, their emerging applications in open clinical or environmental settings require enhanced safety and security measures. Intrinsic biocontainment, the creation of bacterial hosts unable to survive in natural environments, remains a major unsolved biosafety problem. We developed a new biocontainment strategy containing overlapping ‘safeguards’—engineered riboregulators that tightly control expression of essential genes, and an engineered addiction module based on nucleases that cleaves the host genome—to restrict viability of Escherichia coli cells to media containing exogenously supplied synthetic small molecules. These multilayered safeguards maintain robust growth in permissive conditions, eliminate persistence and limit escape frequencies to 〈1.3 x 10 –12 . The staged approach to safeguard implementation revealed mechanisms of escape and enabled strategies to overcome them. Our safeguarding strategy is modular and employs conserved mechanisms that could be extended to clinically or industrially relevant organisms and undomesticated species.
    Print ISSN: 0305-1048
    Electronic ISSN: 1362-4962
    Topics: Biology
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...